Skin lesions in neurofibromatosis type 2: diagnostic and prognostic significance of cutaneous (plexiform) schwannomas.
Journal
Journal of the European Academy of Dermatology and Venereology : JEADV
ISSN: 1468-3083
Titre abrégé: J Eur Acad Dermatol Venereol
Pays: England
ID NLM: 9216037
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
received:
17
11
2021
accepted:
07
04
2022
pubmed:
2
5
2022
medline:
23
8
2022
entrez:
1
5
2022
Statut:
ppublish
Résumé
Neurofibromatosis type 2 (NF2) is a genetic disease characterized by the appearance of multiple tumours in the nervous system. Cutaneous lesions are common and may provide useful diagnostic and prognostic information, but they have not been widely studied. To characterize cutaneous lesions in a Spanish cohort of patients with NF2 and investigate associations with clinical and genetic severity. We studied the clinical and histologic characteristics of cutaneous lesions in 49 patients with NF2 and analysed correlations with phenotype- and genotype-based severity scores. We collected information on the presence/absence of cutaneous lesions, location, age at onset, type of lesion, and histologic features. We also studied level of systemic involvement and genetic mutations involved. Forty-nine patients (31 women [63.3%] and 18 men [36.7%]) were analysed, and 33 (67.3%) had cutaneous lesions presumed to be schwannomas. According to their clinical form, they were distributed as follows: 24 patients (48%) had deep tumours, 21 (42%) had plaque-like lesions, and 3 (6%) had superficial tumours. Histologic examination from 27 lesions analysed out 23 patients showed classic schwannoma or hybrid schwannoma-neurofibroma features in the 8 deep tumours biopsied and plexiform schwannoma features in the 17 plaque-like lesions and the 2 superficial tumours analysed. Early onset (first 2 decades of life) was reported by all patients with plaques and superficial tumours. In our cohort, 100% of the patients with plaque-like lesions and superficial tumours with microscopic features of plexiform schwannoma were in the 2 groups with the most severe clinical phenotypes, and 82.6% of them were in the 3 most severe genotype-based classes. Cutaneous lesions, specially plexiform schwannomas, are common in NF2, and they usually appear at an early age providing useful diagnostic and prognostic information. These tumours are part of the spectrum of cutaneous manifestations in this disease. Although its diagnostic and prognostic value has been pointed out, there are few studies focussed on their analysis.
Sections du résumé
BACKGROUND
BACKGROUND
Neurofibromatosis type 2 (NF2) is a genetic disease characterized by the appearance of multiple tumours in the nervous system. Cutaneous lesions are common and may provide useful diagnostic and prognostic information, but they have not been widely studied.
OBJECTIVES
OBJECTIVE
To characterize cutaneous lesions in a Spanish cohort of patients with NF2 and investigate associations with clinical and genetic severity.
METHODS
METHODS
We studied the clinical and histologic characteristics of cutaneous lesions in 49 patients with NF2 and analysed correlations with phenotype- and genotype-based severity scores. We collected information on the presence/absence of cutaneous lesions, location, age at onset, type of lesion, and histologic features. We also studied level of systemic involvement and genetic mutations involved.
RESULTS
RESULTS
Forty-nine patients (31 women [63.3%] and 18 men [36.7%]) were analysed, and 33 (67.3%) had cutaneous lesions presumed to be schwannomas. According to their clinical form, they were distributed as follows: 24 patients (48%) had deep tumours, 21 (42%) had plaque-like lesions, and 3 (6%) had superficial tumours. Histologic examination from 27 lesions analysed out 23 patients showed classic schwannoma or hybrid schwannoma-neurofibroma features in the 8 deep tumours biopsied and plexiform schwannoma features in the 17 plaque-like lesions and the 2 superficial tumours analysed. Early onset (first 2 decades of life) was reported by all patients with plaques and superficial tumours. In our cohort, 100% of the patients with plaque-like lesions and superficial tumours with microscopic features of plexiform schwannoma were in the 2 groups with the most severe clinical phenotypes, and 82.6% of them were in the 3 most severe genotype-based classes.
CONCLUSIONS AND RELEVANCE
CONCLUSIONS
Cutaneous lesions, specially plexiform schwannomas, are common in NF2, and they usually appear at an early age providing useful diagnostic and prognostic information. These tumours are part of the spectrum of cutaneous manifestations in this disease. Although its diagnostic and prognostic value has been pointed out, there are few studies focussed on their analysis.
Identifiants
pubmed: 35490384
doi: 10.1111/jdv.18190
pmc: PMC9543204
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1632-1640Informations de copyright
© 2022 The Authors. Journal of the European Academy of Dermatology and Venereology published by John Wiley & Sons Ltd on behalf of European Academy of Dermatology and Venereology.
Références
Cancer. 1995 Oct 1;76(7):1181-6
pubmed: 8630895
J Med Genet. 2008 Jun;45(6):332-9
pubmed: 18285426
J Am Acad Dermatol. 1999 Jun;40(6 Pt 1):877-90; quiz 891-2
pubmed: 10365918
Actas Dermosifiliogr. 2016 Jul-Aug;107(6):454-64
pubmed: 26979265
Clin Genet. 2010 Feb;77(2):163-70
pubmed: 19968670
Lancet. 2009 Jun 6;373(9679):1974-86
pubmed: 19476995
Am J Hum Genet. 2002 Oct;71(4):715-23
pubmed: 12235555
Orphanet J Rare Dis. 2009 Jun 19;4:16
pubmed: 19545378
Pediatr Dermatol. 2012 Jul-Aug;29(4):536-8
pubmed: 21906157
Cancers (Basel). 2020 Aug 20;12(9):
pubmed: 32825434
JAMA Dermatol. 2018 Mar 1;154(3):341-346
pubmed: 29322178
Arch Pathol Lab Med. 1996 Apr;120(4):399-401
pubmed: 8619756
Sci Rep. 2017 Jan 04;7:39348
pubmed: 28051113
Arch Dermatol. 1997 Dec;133(12):1539-43
pubmed: 9420538
J Med Genet. 2011 Apr;48(4):261-5
pubmed: 21278391
Arch Dermatol. 2009 Aug;145(8):883-7
pubmed: 19687418
Neuropediatrics. 2005 Feb;36(1):21-34
pubmed: 15776319
J Med Genet. 2022 Jul;59(7):678-686
pubmed: 34348961
J Dermatol. 2007 Jan;34(1):60-4
pubmed: 17204104
Int J Dermatol. 2004 May;43(5):336-40
pubmed: 15117362
Eur J Dermatol. 2011 Nov-Dec;21(6):1010-1
pubmed: 21926040
Pract Neurol. 2010 Apr;10(2):82-93
pubmed: 20308235
J Med Genet. 2017 Oct;54(10):657-664
pubmed: 28848060
Clin Genet. 2019 Aug;96(2):151-162
pubmed: 30993672
Klin Padiatr. 2009 Jul-Aug;221(4):247-50
pubmed: 19629903
J Med Genet. 2015 Oct;52(10):699-705
pubmed: 26275417
World Neurosurg. 2017 Oct;106:653-660
pubmed: 28720529
Histopathology. 1998 Mar;32(3):264-70
pubmed: 9568513
Ann Dermatol. 2009 Nov;21(4):402-5
pubmed: 20523833
Hum Pathol. 2008 May;39(5):633-40
pubmed: 18439936